RSPH vs XBI: Holdings Overlap
RSPHInvesco S&P 500 Equal Weight Health Care ETF
Invesco · 59 holdings · $776M · as of 2026-04-30
XBIState Street® SPDR® S&P® Biotech ETF
State Street (SPDR) · 149 holdings · $10.0B · as of 2026-08-06
Holdings snapshots are 98 days apart (RSPH: 2026-04-30, XBI: 2026-08-06). Weights and index membership change between snapshots, so the true current overlap is typically higher than shown. For funds tracking the same index, the gap can be 5–15 points.
How similar are RSPH and XBI?
Invesco S&P 500 Equal Weight Health Care ETF (RSPH, by Invesco) holds 59 positions; State Street® SPDR® S&P® Biotech ETF (XBI, by State Street (SPDR)) holds 149. They have 8 holdings in common, and by portfolio weight the two funds are 8.8% identical. In practical terms the pair is lightly overlapping, with most of each portfolio distinct.
- Overlap by Weight
- 8.8%Sum of the smaller weight of each shared holding
- Shared Holdings
- 8RSPH holds 59 · XBI holds 149
- Weight in Shared Holdings
- RSPH 13%·XBI 9%Share of each fund's weight in stocks both funds own
Based on each fund's latest official holdings. How is this calculated?
What makes each fund different
Only in RSPH
51 of 59 positions (87.4% of the fund) are not held by XBI. Showing the top 30 by weight.
Only in XBI
141 of 149 positions (91.3% of the fund) are not held by RSPH. Showing the top 30 by weight.
Sector Breakdown
| Sector | RSPH | XBI |
|---|---|---|
| Health Care | 100.5% | 95.5% |
| Other Sectors | 0.0% | 0.0% |
| Unclassified | 0.0% | 4.6% |
Share of each fund's portfolio weight by GICS-style sector, compiled from issuer fund data and our own classification of the holdings, not the issuers' published sector charts. “Unclassified” is weight we could not classify (0% of RSPH, 5% of XBI).
Performance
| Fund | 1M | YTD | 1Y | 3Y (ann.) | 5Y (ann.) | 10Y (ann.) | Yield |
|---|---|---|---|---|---|---|---|
| RSPH | +3.0% | +12.0% | +28.4% | +7.0% | +3.5% | +8.9% | 0.65% |
| XBI | -4.0% | +29.2% | +85.3% | +26.3% | +4.5% | +9.5% | 0.36% |
Total returns including dividends, from adjusted daily closes as of 2026-08-07. 3Y/5Y/10Y are annualized. Yield is trailing-12-month distributions over the last close. Past performance does not predict future results.
Project the growth of $10,000 in RSPH vs XBI →
Shared Holdings(8)
The top 8 shared positions account for 100% of the overlap, led by REGN, AMGN and MRNA.
 REGNRegeneron Pharmaceuticals, Inc. COM | 1.62% | 1.24% | 1.24% |
|---|---|---|---|
 AMGNAmgen Inc. COM | 1.63% | 1.16% | 1.16% |
 MRNAModerna Inc COM | 1.46% | 1.13% | 1.13% |
 INCYIncyte Corporation. COM | 1.79% | 1.09% | 1.09% |
 VRTXVertex Pharmaceuticals Incorporated COM | 1.54% | 1.07% | 1.07% |
 ABBVAbbVie Inc. COM | 1.65% | 1.05% | 1.05% |
 GILDGilead Sciences Inc. COM | 1.59% | 1.04% | 1.04% |
 BIIBBiogen Inc COM | 1.77% | 1.03% | 1.03% |
Frequently Asked Questions
How much do RSPH and XBI overlap?
RSPH and XBI overlap by 8.8% of portfolio weight. They share 8 holdings (RSPH holds 59 positions and XBI holds 149), based on each fund's latest SEC-reported holdings.
Is it redundant to own both RSPH and XBI?
The two portfolios are 8.8% identical by weight. Owning both is not redundant. Most of each portfolio is distinct, so the funds can serve different roles.
What are the biggest shared holdings of RSPH and XBI?
The largest positions held by both funds are REGN, AMGN, MRNA, INCY and VRTX. Together the top 8 shared positions account for 100% of the total overlap.
What does RSPH own that XBI doesn't?
51 positions (87.4% of RSPH) are unique to RSPH, led by CNC, HUM and UNH. In the other direction, 141 positions (91.3% of XBI) are unique to XBI.